Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$103K Buy
2,900
+2,800
+2,800% +$104K ﹤0.01% 5959
2014
Q2
$4K Sell
100
-400
-80% -$14.9K ﹤0.01% 9702
2014
Q1
$18K Sell
500
-500
-50% -$18.2K ﹤0.01% 8249
2013
Q4
$35K Buy
+1,000
New +$32.2K ﹤0.01% 7446

Other funds holding XYL

UBS's XYL Position: Q3 2014 in Review

UBS increased its Xylem (XYL) stake by 1.8% in Q3 2014, buying an estimated $202K and bringing the position to 304,453 shares worth $10.8M. The position accounts for 0.01% of the portfolio, ranked #1394.

UBS first reported a position in XYL in Q2 2013 and has held it in 6 quarters since. The position peaked at $11.7M in Q2 2014. 439 funds tracked by Wall St. Rank hold XYL as of Q3 2014.

  • UBS held 304,453 shares of Xylem worth $10.8M as of Q3 2014.
  • UBS bought 5,438 Xylem shares in Q3 2014, an estimated $202K.
  • Xylem made up 0.01% of UBS's portfolio in Q3 2014, its #1394 holding.
  • UBS first reported a position in Xylem in Q2 2013 and has held it in 6 quarters since.
  • UBS's Xylem position peaked at $11.7M in Q2 2014.
  • 439 funds tracked by Wall St. Rank held Xylem as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.